Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

The Genetic Evolution of Melanoma.

Vogelstein B, Kinzler KW.

N Engl J Med. 2016 Mar 10;374(10):996. doi: 10.1056/NEJMc1515834. No abstract available.

PMID:
26977479
2.

The Genetic Evolution of Melanoma.

Lipsker D.

N Engl J Med. 2016 Mar 10;374(10):995. doi: 10.1056/NEJMc1515834. No abstract available.

PMID:
26962743
3.

The Genetic Evolution of Melanoma.

Shain AH, Bastian BC.

N Engl J Med. 2016 Mar 10;374(10):995-6. doi: 10.1056/NEJMc1515834. No abstract available.

PMID:
26962740
4.

The Genetic Evolution of Melanoma.

Lian CG, Murphy GF.

N Engl J Med. 2016 Mar 10;374(10):994-5. doi: 10.1056/NEJMc1515834. No abstract available.

PMID:
26962742
5.

The Genetic Evolution of Melanoma.

Criscito MC, Polsky D, Stein JA.

N Engl J Med. 2016 Mar 10;374(10):993. doi: 10.1056/NEJMc1515834. No abstract available.

PMID:
26962741
6.

Defining the genetics of melanoma progression.

Burki TK.

Lancet Oncol. 2016 Jan;17(1):e7. doi: 10.1016/S1470-2045(15)00537-9. Epub 2015 Nov 20. No abstract available.

PMID:
26776102
7.

Zosteriform distribution of acantholytic dyskeratotic epidermal nevus?

Elston DM.

J Am Acad Dermatol. 1999 Apr;40(4):647. No abstract available.

PMID:
10188696
8.

The Genetic Evolution of Melanoma from Precursor Lesions.

Shain AH, Yeh I, Kovalyshyn I, Sriharan A, Talevich E, Gagnon A, Dummer R, North J, Pincus L, Ruben B, Rickaby W, D'Arrigo C, Robson A, Bastian BC.

N Engl J Med. 2015 Nov 12;373(20):1926-36. doi: 10.1056/NEJMoa1502583.

9.

Melanocytic Nevi and the Genetic and Epigenetic Control of Oncogene-Induced Senescence.

Huang JM, Chikeka I, Hornyak TJ.

Dermatol Clin. 2017 Jan;35(1):85-93. doi: 10.1016/j.det.2016.08.001. Review.

10.

Melanoma Gene Expression Markers for Surveillance of Epidermolysis Bullosa Nevi Malignant Transformation.

Ahn JW, Johnson K, Kohen LL, Chaffins ML, Shwayder T.

JAMA Dermatol. 2016 May 1;152(5):584-6. doi: 10.1001/jamadermatol.2015.5702. No abstract available.

PMID:
26865206
11.

Telomerase Expression by Aberrant Methylation of the TERT Promoter in Melanoma Arising in Giant Congenital Nevi.

Fan Y, Lee S, Wu G, Easton J, Yergeau D, Dummer R, Vogel P, Kirkwood JM, Barnhill RL, Pappo A, Bahrami A.

J Invest Dermatol. 2016 Jan;136(1):339-342. doi: 10.1038/JID.2015.374. No abstract available.

12.

[Dysplastic nevus syndrome].

Kint A.

Z Hautkr. 1986 May 1;61(9):595-8. German.

PMID:
3716535
13.

Malignant melanoma arising from an NRAS-mutated medium-sized congenital melanocytic nevus.

Kiyohara T, Takata M, Itoh H, Kawami K, Ido H, Ishida H, Kumakiri M.

J Dermatol. 2012 Dec;39(12):1034-5. doi: 10.1111/j.1346-8138.2012.01542.x. Epub 2012 Mar 27. No abstract available.

PMID:
22452623
14.

Molecular pathogenesis of malignant melanoma: a different perspective from the studies of melanocytic nevus and acral melanoma.

Takata M, Murata H, Saida T.

Pigment Cell Melanoma Res. 2010 Feb;23(1):64-71. doi: 10.1111/j.1755-148X.2009.00645.x. Epub 2009 Sep 25. Review.

PMID:
19788535
16.

The PGF(2alpha) receptor FP is lost in nevi and melanoma.

Fricke A, McClelland L, Scott G.

Pigment Cell Melanoma Res. 2010 Feb;23(1):141-3. doi: 10.1111/j.1755-148X.2009.00661.x. Epub 2009 Dec 11. No abstract available.

17.

[Insights into melanoma from a pathologist's perspective].

Mihic-Probst D, Beer M.

Praxis (Bern 1994). 2013 Feb 13;102(4):219-24. doi: 10.1024/1661-8157/a001190. Review. German.

PMID:
23399605
18.

[Risk factors for skin melanoma: genetic factors probably more important than exposure to sunlight].

Pavel S, Smit NP.

Ned Tijdschr Geneeskd. 2004 Nov 13;148(46):2267-72. Review. Dutch.

PMID:
15584541
20.

Re: A prospective study of pigmentation, sun exposure, and risk of cutaneous malignant melanoma in women.

Boniol M, Autier P, Doré JF.

J Natl Cancer Inst. 2004 Feb 18;96(4):335-6; author reply 336-8. No abstract available.

PMID:
14970286

Supplemental Content

Support Center